164 related articles for article (PubMed ID: 19506324)
1. Prognosis of patients with papillary thyroid carcinoma having clinically apparent metastasis to the lateral compartment.
Ito Y; Fukushima M; Tomoda C; Inoue H; Kihara M; Higashiyama T; Uruno T; Takamura Y; Miya A; Kobayashi K; Matsuzuka F; Miyauchi A
Endocr J; 2009; 56(6):759-66. PubMed ID: 19506324
[TBL] [Abstract][Full Text] [Related]
2. Latero-cervical lymph node metastases (N1b) represent an additional risk factor for papillary thyroid cancer outcome.
Sapuppo G; Palermo F; Russo M; Tavarelli M; Masucci R; Squatrito S; Vigneri R; Pellegriti G
J Endocrinol Invest; 2017 Dec; 40(12):1355-1363. PubMed ID: 28646475
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of extranodal extension of regional lymph node metastasis in papillary thyroid cancer.
Wu MH; Shen WT; Gosnell J; Duh QY
Head Neck; 2015 Sep; 37(9):1336-43. PubMed ID: 24821456
[TBL] [Abstract][Full Text] [Related]
4. Patterns, Predictive Factors, and Prognostic Impact of Contralateral Lateral Lymph Node Metastasis in N1b Papillary Thyroid Carcinoma.
Kim SK; Park I; Hur N; Rayzah M; Lee JH; Choe JH; Kim JH; Kim JS
Ann Surg Oncol; 2017 Jul; 24(7):1943-1950. PubMed ID: 28160142
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for recurrent disease in small papillary thyroid cancers - a Swedish register-based study.
Bayadsi H; Nylén C; Sandström M; Angelsten J; Sund M; Hennings J
Langenbecks Arch Surg; 2023 Apr; 408(1):162. PubMed ID: 37099203
[TBL] [Abstract][Full Text] [Related]
6. Prognostic values of clinical lymph node metastasis and macroscopic extrathyroid extension in papillary thyroid carcinoma.
Ito Y; Miyauchi A; Kihara M; Kobayashi K; Miya A
Endocr J; 2014; 61(8):745-50. PubMed ID: 24739332
[TBL] [Abstract][Full Text] [Related]
7. Not all DTC patients with N positive disease deserve the attribution "high risk". Contribution of the MSDS trial.
Vrachimis A; Wenning C; Gerß J; Dralle H; Vaez Tabassi M; Schober O; Riemann B;
J Surg Oncol; 2015 Jul; 112(1):9-14. PubMed ID: 26074402
[TBL] [Abstract][Full Text] [Related]
8. Modification of the eight-edition tumor-node-metastasis staging system with N1b for papillary thyroid carcinoma: A multi-institutional cohort study.
Kim M; Kim HK; Kim HI; Kim EH; Jeon MJ; Yi HS; Kim ES; Kim H; Kim TH; Kim BH; Kim TY; Kang HC; Kim WB; Chung JH; Shong YK; Kim SW; Kim WG
Oral Oncol; 2018 Nov; 86():48-52. PubMed ID: 30409319
[TBL] [Abstract][Full Text] [Related]
9. Risk factors contributing to a poor prognosis of papillary thyroid carcinoma: validity of UICC/AJCC TNM classification and stage grouping.
Ito Y; Miyauchi A; Jikuzono T; Higashiyama T; Takamura Y; Miya A; Kobayashi K; Matsuzuka F; Ichihara K; Kuma K
World J Surg; 2007 Apr; 31(4):838-48. PubMed ID: 17347900
[TBL] [Abstract][Full Text] [Related]
10. Occult papillary thyroid carcinoma: diagnostic and clinical implications in the era of routine ultrasonography.
Ito Y; Hirokawa M; Fukushima M; Inoue H; Yabuta T; Uruno T; Kihara M; Higashiyama T; Takamura Y; Miya A; Kobayashi K; Matsuzuka F; Miyauchi A
World J Surg; 2008 Sep; 32(9):1955-60. PubMed ID: 18594906
[TBL] [Abstract][Full Text] [Related]
11. The prognostic significance of nodal metastases from papillary thyroid carcinoma can be stratified based on the size and number of metastatic lymph nodes, as well as the presence of extranodal extension.
Randolph GW; Duh QY; Heller KS; LiVolsi VA; Mandel SJ; Steward DL; Tufano RP; Tuttle RM;
Thyroid; 2012 Nov; 22(11):1144-52. PubMed ID: 23083442
[TBL] [Abstract][Full Text] [Related]
12. Heterogeneous Prognoses for pT3 Papillary Thyroid Carcinomas and Impact of Delayed Risk Stratification.
Tavarelli M; Sarfati J; Chereau N; Tissier F; Golmard JL; Ghander C; Lussey-Lepoutre C; Trésallet C; Menegaux F; Leenhardt L; Buffet C
Thyroid; 2017 Jun; 27(6):778-786. PubMed ID: 28351220
[TBL] [Abstract][Full Text] [Related]
13. Investigation of the prognosis of patients with papillary thyroid carcinoma by tumor size.
Ito Y; Fukushima M; Kihara M; Takamura Y; Kobayashi K; Miya A; Miyauchi A
Endocr J; 2012; 59(6):457-64. PubMed ID: 22447137
[TBL] [Abstract][Full Text] [Related]
14. The prognostic value of the metastatic lymph node ratio and maximal metastatic tumor size in pathological N1a papillary thyroid carcinoma.
Jeon MJ; Yoon JH; Han JM; Yim JH; Hong SJ; Song DE; Ryu JS; Kim TY; Shong YK; Kim WB
Eur J Endocrinol; 2013 Feb; 168(2):219-25. PubMed ID: 23161752
[TBL] [Abstract][Full Text] [Related]
15. Prognostic impact of extrathyroid extension and clinical lymph node metastasis in papillary thyroid carcinoma depend on carcinoma size.
Fukushima M; Ito Y; Hirokawa M; Miya A; Shimizu K; Miyauchi A
World J Surg; 2010 Dec; 34(12):3007-14. PubMed ID: 20824274
[TBL] [Abstract][Full Text] [Related]
16. Extent of Extrathyroidal Extension as a Significant Predictor of Nodal Metastasis and Extranodal Extension in Patients with Papillary Thyroid Carcinoma.
Kim JW; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
Ann Surg Oncol; 2017 Feb; 24(2):460-468. PubMed ID: 27654105
[TBL] [Abstract][Full Text] [Related]
17. Guiding the postoperative radioactive iodine-131 therapy for patients with papillary thyroid carcinoma according to the prognostic risk groups: a SEER-based study.
Yang Y; Gan M; Yi K; Han S; Lin Z; Shi Y; Ming J
J Cancer Res Clin Oncol; 2023 Dec; 149(19):17147-17157. PubMed ID: 37782329
[TBL] [Abstract][Full Text] [Related]
18. Correlation between the number of lymph node metastases and lung metastasis in papillary thyroid cancer.
Machens A; Dralle H
J Clin Endocrinol Metab; 2012 Dec; 97(12):4375-82. PubMed ID: 23019347
[TBL] [Abstract][Full Text] [Related]
19. Relationship between prognosis of papillary thyroid carcinoma patient and age: a retrospective single-institution study.
Ito Y; Miyauchi A; Kihara M; Takamura Y; Kobayashi K; Miya A
Endocr J; 2012; 59(5):399-405. PubMed ID: 22374240
[TBL] [Abstract][Full Text] [Related]
20. Routine Level 2b Dissection may be Recommended Only in N1b Papillary Thyroid Carcinoma with Three- or Four-Level Lateral Lymph Node Metastasis.
Kim SK; Park I; Hur N; Lee JH; Choe JH; Kim JH; Kim JS
Ann Surg Oncol; 2016 Dec; 23(Suppl 5):694-700. PubMed ID: 27654111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
